APTIVUS 250mg capsule me medication leaflet

J05AE09 • tipranavir • Antiinfectives for systemic use | Direct acting antivirals | Protease inhibitors

Tipranavir is a protease inhibitor used in the treatment of HIV-1 infection in patients who have developed resistance to other antiretroviral therapies. It works by inhibiting the HIV protease enzyme, preventing the virus from replicating.

The medication is taken orally, usually in combination with ritonavir to enhance its effectiveness. The dosage and duration of treatment are adjusted based on the patient's response and treatment history.

Patients should be closely monitored to detect potential side effects, such as gastrointestinal disturbances, elevated liver enzymes, or allergic reactions. It is important for patients to strictly adhere to the treatment regimen.

Common side effects include diarrhea, nausea, fatigue, and headache. In rare cases, severe reactions such as hepatotoxicity or intracranial hemorrhages may occur. Patients should be informed of these risks before starting treatment.